Joanna Horobin
CIK 1560959 · Chief Medical Officer · last filed 2025-08-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.41M
Companies
5
Total Filings
32
Lifetime Open-Market Net
-$408.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LQDA | Director | 33,755 | $71.23 | $2.40M | -$135.8K | 7 | 2025-08-21 |
| KYMR | Director | 0 | $86.20 | $0 | -$280.4K | 5 | 2024-06-07 |
| Vyant Bio, Inc. (VYNT) Delisted | Director | 23,123 | $0.19 | $4.5K | $0 | 7 | 2023-01-19 |
| Aceragen, Inc. (IDRA) Delisted | Chief Medical Officer | 20,144 | $7.22 | $145.5K | $1.0K | 7 | 2019-07-11 |
| VSTM | Chief Medical Officer | 750 | $4.10 | $3.1K | $6.5K | 4 | 2015-01-12 |
Recent Filings · Page 3 of 4
32 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-09-12 | — | Grant (A) | — | $0 | |
| 2019-07-11 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-01-07 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | +18,100 | $0 | EDGAR |
| 2018-12-20 | Aceragen, Inc. (IDRA) Delisted | Buy (P) | +300 | $1.0K | EDGAR |
| 2018-08-15 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-01-05 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-01-06 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-12-02 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-01-12 | VSTM | Grant (A) | — | $0 | EDGAR |
| 2014-12-31 | VSTM | Buy (P) | +750 | $6.5K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.